My watch list
my.bionity.com  
Login  

216 Current news from israel

rss
matching the following criteria

CMC Biologics Expands GMP Manufacturing Capacity in the United States and Europe

Company plans to add more than 30,000L of bioreactor capacity across its three sites

11-May-2015

CMC Biologics, Inc announced a plan to expand its global manufacturing capacity by more than 30,000 liters in the United States and Europe to meet growing customer demands for late-stage and commercial manufacturing."This global expansion addresses increasing demands from our customers for ...

more

Ascendis Pharma A/S Announces Results of Phase 1 Study of TransCon Treprostinil

04-May-2015

Ascendis Pharma A/S announced that its Phase 1 single ascending dose study of TransCon Treprostinil produced dose-dependent increases in plasma treprostinil levels in-line with expectations. However, treprostinil-related injection-site tolerability issues did not meet the criteria defined in ...

more

Genmab Announces Phase III Study of Arzerra® Met Primary Endpoint of Improved Progression-Free Survival in Patients with Relapsed CLL

29-Apr-2015

Genmab A/S announced that the top-line results from the Phase III COMPLEMENT 2 study showed that treatment with Arzerra® (ofatumumab) plus fludarabine and cyclophosphamide met the primary endpoint of improved progression-free survival (PFS) in patients with relapsed CLL (p = 0.0036) compared to ...

more

Antibiotic Armageddon in UK and Europe by 2025

ESCMID warns that Europe may surpass one million deaths due to ineffective antibiotics by 2025

23-Apr-2015

The European Society of Clinical Microbiology and Infectious Disease (ESCMID) – an organization that explores risk assessment, knowledge sharing and best practices in the fight against infectious disease – has warned that Britain and Europe collectively could face more than a million deaths in an ...

more

Vaccine against Placental Malaria is ready to start human tests

24-Mar-2015

ExpreS2ion Biotechnologies announced the release by its partners at University of Copenhagen, of a vaccine candidate against the form of malaria that strikes pregnant women, for testing in humans. The vaccine candidate contains a malaria antigen made with ExpreS2ion’s proprietary protein ...

more

Genmab Acquires Antibody Assets from iDD Biotech

20-Mar-2015

Genmab A/S announced that its subsidiary Genmab Holding B.V. entered into an agreement to purchase antibodies and related patents and know-how from iDD Biotech SAS. The pre-clinical stage antibodies are directed to DR5, also known as Trail Receptor 2 (TRAIL-R2), an emerging cancer target. ...

more

Recipharm appoints new position of Vice President Quality Management

11-Mar-2015

Recipharm announced that it has appointed Thomas Beck to the new senior role of Vice President Quality Management (VP QM) with effect from 1st April 2015. Thomas is currently Head of Quality Control and Assurance at Recipharm Stockholm, a position that he has held since 2010. He is also Chairman ...

more

Genmab Enters Commercial DuoBody Technology Agreement with BioNovion in the Field of Immuno-Oncology

23-Feb-2015

Genmab A/S announced it has entered a co-development and commercialization agreement with BioNovion to evaluate a number of DuoBody product candidates targeting immune checkpoints. Genmab and BioNovion will contribute panels of antibodies for the creation of bispecific antibody products using ...

more

Genmab Announces Preliminary Results in Phase II Study of Daratumumab in Double Refractory Multiple Myeloma

05-Feb-2015

Genmab A/S announced preliminary results from the Phase II study of daratumumab in double refractory multiple myeloma conducted by its collaboration partner Janssen Biotech, Inc. (Janssen). The overall response rate (ORR) in the study was 29.2% in the 16 mg/kg dosing group and the median ...

more

Ascendis Pharma A/S Announces Initiation of a Phase 1 Single Ascending Dose Study of TransCon Treprostinil

16-Jan-2015

Ascendis Pharma A/S announced that it has initiated a Phase 1 single ascending dose study of TransCon Treprostinil in healthy volunteers. TransCon Treprostinil is being developed to treat pulmonary arterial hypertension, a life-threatening orphan disease characterized by elevated blood pressure ...

more

Page 1 From 22
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE